Evolutionary Genomics, Inc. (FNAM)

USD 0.0

(0.0%)

Eps Summary of Evolutionary Genomics, Inc.

  • Evolutionary Genomics, Inc.'s latest annual eps in 2022 was -0.35 USD , up 36.96% from previous year.
  • Evolutionary Genomics, Inc.'s latest quarterly eps in 2023 Q2 was - USD , down 0.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported an annual eps of -0.46 USD in 2021, down -58.62% from previous year.
  • Evolutionary Genomics, Inc. reported an annual eps of -0.29 USD in 2020, down -123.08% from previous year.
  • Evolutionary Genomics, Inc. reported a quarterly eps of - USD for 2023 Q1, up 100.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported a quarterly eps of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Eps Chart of Evolutionary Genomics, Inc. (2022 - 2009)

Historical Annual Eps of Evolutionary Genomics, Inc. (2022 - 2009)

Year Eps Eps Growth
2022 -0.35 USD 36.96%
2021 -0.46 USD -58.62%
2020 -0.29 USD -123.08%
2019 -0.13 USD 31.58%
2018 -0.19 USD -107.2%
2017 -0.09 USD 54.15%
2016 -0.20 USD -243.05%
2015 -0.06 USD -871.67%
2014 -0.01 USD 96.0%
2013 -0.15 USD -15.38%
2012 -0.13 USD 0.0%
2011 -0.13 USD 27.78%
2010 -0.18 USD -28.57%
2009 -0.14 USD 0.0%

Peer Eps Comparison of Evolutionary Genomics, Inc.

Name Eps Eps Difference
America Great Health - USD Infinity%
Ampio Pharmaceuticals, Inc. -10.67 USD 96.72%
Aridis Pharmaceuticals, Inc. -1.64 USD 78.659%
Biora Therapeutics, Inc. -7.87 USD 95.553%
Bio-Path Holdings, Inc. -33.64 USD 98.96%
Better Therapeutics, Inc. -1.69 USD 79.29%
Calithera Biosciences, Inc. -7.94 USD 95.592%
Comera Life Sciences Holdings, Inc. -1.76 USD 80.114%
Gene Biotherapeutics, Inc. - USD Infinity%
eFFECTOR Therapeutics, Inc. -16.37 USD 97.862%
Eloxx Pharmaceuticals, Inc. -16.65 USD 97.898%
Evelo Biosciences, Inc. -26.28 USD 98.668%
Finch Therapeutics Group, Inc. -46.59 USD 99.249%
Galera Therapeutics, Inc. -1.33 USD 73.684%
Innovation1 Biotech Inc. -0.70 USD 50.0%
Kiromic BioPharma, Inc. -21.41 USD 98.365%
Molecular Templates, Inc. -1.80 USD 80.556%
Navidea Biopharmaceuticals, Inc. -0.59 USD 40.678%
NexImmune, Inc. -30.82 USD 98.864%
Orgenesis Inc. -1.91 USD 81.675%
Panbela Therapeutics, Inc. -232.42 Thousand USD 100.0%
Point of Care Nano-Technology, Inc. -0.10 USD -250.0%
PaxMedica, Inc. Common Stock -11.00 USD 96.818%
Scopus BioPharma Inc. -0.55 USD 36.364%
Sorrento Therapeutics, Inc. -1.37 USD 74.453%
Statera Biopharma, Inc. -4.97 USD 92.958%
TRACON Pharmaceuticals, Inc. -2.20 USD 84.091%
Trevena, Inc. -54.51 USD 99.358%
Vaxxinity, Inc. -0.45 USD 22.222%
Vaccinex, Inc. -43.68 USD 99.199%
Vicapsys Life Sciences, Inc. -0.03 USD -923.392%
Viracta Therapeutics, Inc. -1.32 USD 73.485%
ZIVO Bioscience, Inc. -4.60 USD 92.391%